SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-64K
|
$2.60
|
-$165.37K
|
|
SEC
|
Drummond Stuart
|
Interim CFO
|
|
+5K
|
$9.80
|
+$49.00K
|
|
SEC
|
Harris Taylor C.
|
Chief Executive Officer
|
|
+30K
|
$9.91
|
+$297.30K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-34
|
$34.57
|
-$1.18K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-90
|
$34.57
|
-$3.11K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-51
|
$34.57
|
-$1.76K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
+875
|
$19.24
|
+$16.84K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+1.8K
|
$18.79
|
+$32.94K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
+1.9K
|
$15.90
|
+$29.69K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-49
|
$49.97
|
-$2.45K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-170
|
$49.97
|
-$8.49K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-51
|
$49.97
|
-$2.55K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-50
|
$45.29
|
-$2.26K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-170
|
$45.29
|
-$7.70K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-50
|
$46.09
|
-$2.30K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-169
|
$46.09
|
-$7.79K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-50
|
$47.20
|
-$2.36K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-90
|
$47.20
|
-$4.25K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-49
|
$45.69
|
-$2.24K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-90
|
$45.69
|
-$4.11K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-47
|
$45.69
|
-$2.15K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-9.1K
|
$40.24
|
-$364.37K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-50
|
$37.54
|
-$1.88K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-90
|
$37.54
|
-$3.38K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-49
|
$37.54
|
-$1.84K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-50
|
$44.41
|
-$2.22K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-90
|
$44.41
|
-$4.00K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-48
|
$44.41
|
-$2.13K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-1.7K
|
$51.00
|
-$88.13K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+996
|
$50.12
|
+$49.92K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+15K
|
$22.87
|
+$353.94K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
+4.9K
|
$23.48
|
+$115.26K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
+4.1K
|
$0.60
|
+$2.44K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-83
|
$72.31
|
-$6.00K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-46
|
$72.31
|
-$3.33K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
+3.2K
|
$10.63
|
+$33.65K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+4.1K
|
$13.67
|
+$56.43K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
+2.9K
|
$11.33
|
+$32.34K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+2.5K
|
$40.81
|
+$100.11K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-34
|
$38.15
|
-$1.30K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-83
|
$38.15
|
-$3.17K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-39
|
$38.15
|
-$1.49K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-34
|
$36.30
|
-$1.23K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-83
|
$36.30
|
-$3.01K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-38
|
$36.30
|
-$1.38K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-2.6K
|
$39.88
|
-$103.93K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-2.8K
|
$39.88
|
-$113.10K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
-339
|
$39.88
|
-$13.52K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
+500
|
$35.17
|
+$17.59K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
+1.2K
|
$35.38
|
+$41.54K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+1.4K
|
$35.15
|
+$49.81K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+2.8K
|
$35.91
|
+$99.97K
|
|
SEC
|
PLANTS J DANIEL
|
Exec. Chairman of the Board
|
|
+1K
|
$35.27
|
+$35.27K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
+1K
|
$34.72
|
+$34.72K
|
|
SEC
|
Zanotti Katherine S
|
N/A
|
|
+1.3K
|
$37.63
|
+$49.18K
|
|
SEC
|
PLANTS J DANIEL
|
Exec. Chairman of the Board
|
|
+14K
|
$11.98
|
+$167.72K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-432
|
$48.81
|
-$21.09K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+3K
|
$47.97
|
+$143.91K
|
|
SEC
|
WHITTERS JOSEPH E
|
N/A
|
|
+1.5K
|
$53.89
|
+$80.84K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-8.4K
|
$47.74
|
-$399.87K
|
|
SEC
|
Karavitis Michael
|
EVP, Chief Technology Officer
|
|
-1.2K
|
$36.13
|
-$43.83K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+665K
|
$29.50
|
+$19.61M
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+8.6K
|
$9.45
|
+$81.35K
|
|
SEC
|
Seth Rohan
|
Chief Financial Officer
|
|
+6.5K
|
$6.10
|
+$39.91K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+1.2K
|
$8.80
|
+$10.52K
|
|
SEC
|
Richey Robert Jason
|
President
|
|
-2.1K
|
$5.99
|
-$12.73K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-1.3K
|
$23.74
|
-$31.76K
|
|
SEC
|
Richey Robert Jason
|
President
|
|
-2.3K
|
$23.74
|
-$53.42K
|
|
SEC
|
Zanotti Katherine S
|
N/A
|
|
+3.1K
|
$16.36
|
+$50.47K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+60K
|
$14.90
|
+$890.56K
|
|
SEC
|
Richey Robert Jason
|
President
|
|
-5.6K
|
$11.44
|
-$63.88K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
-5K
|
$11.80
|
-$58.68K
|
|
SEC
|
Richey Robert Jason
|
President
|
|
-2.7K
|
$11.80
|
-$31.52K
|
|
SEC
|
Barrett Gregory A
|
N/A
|
|
+19K
|
$10.50
|
+$199.99K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+95K
|
$10.50
|
+$1.00M
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+15K
|
$2.85
|
+$41.75K
|
|
SEC
|
Richey Robert Jason
|
President
|
|
+20K
|
$3.58
|
+$72.75K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+6.2K
|
$2.98
|
+$18.33K
|
|
SEC
|
Richey Robert Jason
|
President
|
|
+11K
|
$3.75
|
+$40.06K
|
|
SEC
|
Mowry David H
|
Chief Executive Officer
|
|
+5.2K
|
$19.22
|
+$99.94K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+8.9K
|
$21.82
|
+$194.20K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+50K
|
$24.17
|
+$1.21M
|
|
SEC
|
Richey Robert Jason
|
President
|
|
+51K
|
$1.30
|
+$66.12K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+200
|
$16.47
|
+$3.29K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+28K
|
$16.73
|
+$471.22K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+7.1K
|
$16.95
|
+$121.11K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+87K
|
$16.96
|
+$1.47M
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
+12K
|
$16.94
|
+$208.63K
|
|
SEC
|
WHITTERS JOSEPH E
|
N/A
|
|
+27K
|
$16.74
|
+$453.65K
|
|
SEC
|
GARDINER SANDRA A.
|
EVP & Chief Financial Officer
|
|
+1.1K
|
$6.47
|
+$6.85K
|
|
SEC
|
Reinstein James A.
|
President and CEO
|
|
+447
|
$8.13
|
+$3.63K
|
|
SEC
|
GARDINER SANDRA A.
|
EVP & Chief Financial Officer
|
|
-442
|
$20.50
|
-$9.06K
|
|
SEC
|
Reinstein James A.
|
President and CEO
|
|
+1K
|
$32.02
|
+$32.02K
|
|
SEC
|
Richey Robert Jason
|
Chief Operating Officer
|
|
+57K
|
$42.61
|
+$2.42M
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-11K
|
$43.43
|
-$492.71K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-1.2K
|
$44.20
|
-$52.69K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-892
|
$41.02
|
-$36.59K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-17K
|
$39.37
|
-$676.18K
|
|
SEC
|
Barrett Gregory A
|
N/A
|
|
+5.5K
|
$36.98
|
+$201.54K
|
|
SEC
|
FINNEY ELISHA W
|
N/A
|
|
+2K
|
$35.60
|
+$71.20K
|
|
SEC
|
Reinstein James A.
|
President and CEO
|
|
+2.8K
|
$35.55
|
+$99.54K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
+4.2K
|
$16.73
|
+$69.55K
|
|
SEC
|
Reinstein James A.
|
President and CEO
|
|
+6.8K
|
$15.37
|
+$104.90K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-1K
|
$47.40
|
-$47.40K
|
|
SEC
|
Pardos Miguel
|
EVP, International Sales
|
|
-5K
|
$34.46
|
-$172.30K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-1K
|
$42.55
|
-$42.55K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
-280K
|
$44.00
|
-$12.32M
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-1.3K
|
$44.30
|
-$55.38K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-2.2K
|
$42.00
|
-$92.40K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-4K
|
$41.00
|
-$164.00K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-469
|
$39.00
|
-$18.29K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-1K
|
$39.90
|
-$39.90K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-500
|
$40.50
|
-$20.25K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-1K
|
$38.45
|
-$38.45K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-3.8K
|
$39.85
|
-$149.76K
|
|
SEC
|
SANTILLI RONALD J
|
Outgoing EVP and CFO
|
|
-5.8K
|
$40.43
|
-$233.48K
|
|
SEC
|
SANTILLI RONALD J
|
Outgoing EVP and CFO
|
|
-2.9K
|
$34.00
|
-$100.20K
|
|
SEC
|
SANTILLI RONALD J
|
Outgoing EVP and CFO
|
|
-29K
|
$34.01
|
-$969.93K
|
|
SEC
|
SANTILLI RONALD J
|
Outgoing EVP and CFO
|
|
-1.1K
|
$33.20
|
-$35.46K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-1K
|
$25.88
|
-$25.88K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-10K
|
$25.08
|
-$250.80K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-4K
|
$39.21
|
-$156.84K
|
|
SEC
|
Reinstein James A.
|
President and CEO
|
|
+880
|
$22.75
|
+$20.02K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-2.6K
|
$24.36
|
-$62.43K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-957
|
$22.95
|
-$21.96K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-3.9K
|
$22.95
|
-$88.52K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-1.5K
|
$17.29
|
-$25.62K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-39K
|
$22.31
|
-$874.64K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-21K
|
$19.90
|
-$415.03K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-18K
|
$15.39
|
-$271.76K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
+4.4K
|
$15.28
|
+$66.50K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
+4.1K
|
$5.59
|
+$22.98K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
+14K
|
$5.59
|
+$80.49K
|
|
SEC
|
Reinstein James A.
|
President and CEO
|
|
+2.4K
|
$20.20
|
+$48.48K
|
|
SEC
|
PLANTS J DANIEL
|
N/A
|
|
-250K
|
$20.25
|
-$5.06M
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-25K
|
$20.40
|
-$510.00K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
+12K
|
$20.61
|
+$254.06K
|
|
SEC
|
Laber Larry
|
EVP, North America Sales
|
|
-1.5K
|
$21.97
|
-$32.96K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-6K
|
$20.52
|
-$123.12K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-7.5K
|
$13.19
|
-$98.77K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-18K
|
$17.01
|
-$304.72K
|
|
SEC
|
SANTILLI RONALD J
|
Interim CEO and CFO
|
|
-11K
|
$13.89
|
-$154.07K
|
|
SEC
|
SANTILLI RONALD J
|
Interim CEO and CFO
|
|
-53K
|
$14.05
|
-$749.51K
|
|
SEC
|
CONNORS KEVIN P
|
President & CEO
|
|
-33K
|
$10.58
|
-$350.18K
|
|
SEC
|
CONNORS KEVIN P
|
President & CEO
|
|
-65K
|
$11.37
|
-$742.42K
|
|
SEC
|
WIDMAN JERRY P
|
N/A
|
|
-12K
|
$12.01
|
-$144.12K
|
|
SEC
|
SANTILLI RONALD J
|
EVP & CFO
|
|
-32K
|
$15.00
|
-$473.99K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-900
|
$14.91
|
-$13.42K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-6.4K
|
$15.04
|
-$96.98K
|
|
SEC
|
WIDMAN JERRY P
|
N/A
|
|
-10K
|
$14.95
|
-$149.50K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-32K
|
$15.00
|
-$477.15K
|
|
SEC
|
SANTILLI RONALD J
|
EVP & CFO
|
|
-32K
|
$14.99
|
-$475.96K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-10K
|
$14.99
|
-$149.90K
|
|
SEC
|
CONNORS KEVIN P
|
President & CEO
|
|
-5K
|
$14.90
|
-$74.65K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-4.1K
|
$14.35
|
-$58.62K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-7K
|
$14.08
|
-$98.56K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-21K
|
$14.00
|
-$300.15K
|
|
SEC
|
SANTILLI RONALD J
|
EVP & CFO
|
|
-26K
|
$14.00
|
-$357.55K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-2K
|
$14.17
|
-$27.79K
|
|
SEC
|
SANTILLI RONALD J
|
EVP & CFO
|
|
-2K
|
$14.17
|
-$27.79K
|
|
SEC
|
CONNORS KEVIN P
|
President & CEO
|
|
-34K
|
$13.41
|
-$450.52K
|
|
SEC
|
CONNORS KEVIN P
|
President & CEO
|
|
-100K
|
$13.11
|
-$1.31M
|
|
SEC
|
WIDMAN JERRY P
|
N/A
|
|
-7K
|
$13.12
|
-$91.84K
|
|
SEC
|
SANTILLI RONALD J
|
EVP & CFO
|
|
-64K
|
$13.35
|
-$850.40K
|
|
SEC
|
SEVERSON CLINTON
|
N/A
|
|
+4K
|
$12.50
|
+$50.00K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-6.2K
|
$10.46
|
-$64.97K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-13K
|
$9.15
|
-$115.40K
|
|
SEC
|
GOLLNICK DAVID A
|
N/A
|
|
-53K
|
$13.13
|
-$694.80K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-7.1K
|
$12.65
|
-$89.36K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-6.4K
|
$13.00
|
-$83.01K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-16K
|
$12.55
|
-$203.45K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-6.4K
|
$13.00
|
-$83.01K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-15K
|
$12.03
|
-$177.48K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-125K
|
$12.16
|
-$1.52M
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-6.8K
|
$7.48
|
-$50.49K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-2.7K
|
$7.47
|
-$20.17K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
+12K
|
$7.29
|
+$87.48K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-3.4K
|
$9.06
|
-$30.55K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-1.8K
|
$9.28
|
-$16.24K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-5K
|
$7.04
|
-$35.20K
|
|
SEC
|
SANTILLI RONALD J
|
EVP and CFO
|
|
-15K
|
$7.22
|
-$108.30K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-7.3K
|
$9.82
|
-$71.76K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-38K
|
$15.23
|
-$571.13K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-60K
|
$15.23
|
-$913.80K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-38K
|
$14.91
|
-$559.13K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-38K
|
$14.97
|
-$561.38K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-38K
|
$16.70
|
-$626.25K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-30K
|
$24.45
|
-$733.50K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-30K
|
$24.13
|
-$723.90K
|
|
SEC
|
Connors John
|
VP of North American Sales
|
|
-7.5K
|
$36.69
|
-$275.18K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$37.22
|
-$372.20K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-35K
|
$37.25
|
-$1.30M
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-100K
|
$37.07
|
-$3.71M
|
|
SEC
|
Shine Robert John Jr
|
VP of International
|
|
-3K
|
$37.35
|
-$112.05K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$37.06
|
-$370.60K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$35.00
|
-$350.00K
|
|
SEC
|
Connors John
|
VP of North American Sales
|
|
-9.9K
|
$27.61
|
-$273.81K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-5K
|
$28.40
|
-$142.00K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$28.35
|
-$283.50K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-33K
|
$28.06
|
-$931.11K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-21K
|
$28.51
|
-$604.16K
|
|
SEC
|
Shine Robert John Jr
|
VP of International
|
|
-5K
|
$28.28
|
-$141.40K
|
|
SEC
|
Connors John
|
VP of North American Sales
|
|
-8.1K
|
$23.21
|
-$187.61K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-5K
|
$23.15
|
-$115.75K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-3.8K
|
$25.13
|
-$94.99K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-6.2K
|
$25.18
|
-$156.62K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-30K
|
$23.92
|
-$717.60K
|
|
SEC
|
CAMPBELL WHITE ANNETTE
|
N/A
|
|
+5K
|
$25.23
|
+$126.15K
|
|
SEC
|
Liolios Thomas John
|
VP of International
|
|
-742
|
$39.41
|
-$29.24K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-40K
|
$38.22
|
-$1.54M
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-10K
|
$37.00
|
-$370.00K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-7.5K
|
$39.00
|
-$292.50K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-18K
|
$38.10
|
-$685.80K
|
|
SEC
|
Connors John
|
VP of North American Sales
|
|
-10K
|
$38.18
|
-$381.80K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-7.5K
|
$37.39
|
-$280.43K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-108K
|
$35.37
|
-$3.80M
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-20K
|
$33.53
|
-$670.60K
|
|
SEC
|
OShea Timothy J
|
N/A
|
|
-10K
|
$33.29
|
-$332.90K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-15K
|
$34.20
|
-$513.00K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$32.70
|
-$327.00K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-5K
|
$26.75
|
-$133.75K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$24.67
|
-$98.68K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$23.33
|
-$116.65K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$23.72
|
-$94.88K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$25.39
|
-$126.95K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$25.36
|
-$101.44K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$25.30
|
-$126.50K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$25.55
|
-$102.20K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$24.52
|
-$122.60K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$23.65
|
-$94.60K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-80K
|
$23.03
|
-$1.84M
|
|
SEC
|
Connors John
|
VP of North American Sales
|
|
-7K
|
$23.10
|
-$161.70K
|
|
SEC
|
Connors John
|
VP of North American Sales
|
|
-3K
|
$22.81
|
-$68.43K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$22.71
|
-$90.84K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$21.08
|
-$105.40K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$21.87
|
-$87.48K
|
|
SEC
|
NOHRA GUY P
|
N/A
|
|
-1.7K
|
$23.33
|
-$40.52K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$21.87
|
-$109.35K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$22.00
|
-$88.00K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-5K
|
$22.00
|
-$110.00K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$21.99
|
-$109.95K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-15K
|
$22.25
|
-$333.75K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$21.70
|
-$86.80K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$22.03
|
-$220.30K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$20.98
|
-$209.80K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$18.50
|
-$92.50K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-10K
|
$20.02
|
-$200.20K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$18.67
|
-$74.68K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$18.48
|
-$92.40K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$18.95
|
-$75.80K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$16.24
|
-$64.96K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$16.58
|
-$54.71K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$16.88
|
-$55.70K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$17.67
|
-$58.31K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$17.88
|
-$35.76K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$16.23
|
-$53.56K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$16.25
|
-$65.00K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$15.34
|
-$50.62K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$14.75
|
-$59.00K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$15.32
|
-$50.56K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$15.69
|
-$62.76K
|
|
SEC
|
Connors John
|
VP of North American Sales
|
|
-5K
|
$16.09
|
-$80.45K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$15.39
|
-$50.79K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$14.29
|
-$71.45K
|
|
SEC
|
CAMPBELL WHITE ANNETTE
|
N/A
|
|
+5K
|
$14.71
|
+$73.55K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$14.93
|
-$59.72K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$15.46
|
-$77.30K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$15.23
|
-$60.92K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$15.55
|
-$51.32K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$15.17
|
-$75.85K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$15.65
|
-$62.60K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-3.3K
|
$16.52
|
-$54.52K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.44
|
-$87.20K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$17.71
|
-$70.84K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-2.7K
|
$18.00
|
-$49.28K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-7.3K
|
$18.00
|
-$130.72K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$16.85
|
-$33.70K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.12
|
-$85.60K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$17.06
|
-$68.24K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$17.77
|
-$35.54K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.80
|
-$89.00K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.28
|
-$86.40K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$17.59
|
-$70.36K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$17.25
|
-$34.50K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$18.01
|
-$90.05K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$18.93
|
-$75.72K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$19.60
|
-$39.20K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$19.23
|
-$96.15K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$18.48
|
-$73.92K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$18.65
|
-$37.30K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$19.08
|
-$95.40K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-4K
|
$19.02
|
-$76.08K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$18.99
|
-$37.98K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$18.40
|
-$92.00K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$18.48
|
-$36.96K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$17.42
|
-$34.84K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$18.56
|
-$92.80K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$18.77
|
-$37.54K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$18.68
|
-$37.36K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.75
|
-$88.75K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$17.34
|
-$34.68K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$17.87
|
-$35.74K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.90
|
-$89.50K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$17.68
|
-$35.36K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$16.07
|
-$32.14K
|
|
SEC
|
MAYNOR KATHLEEN A
|
VP of Regulary Affairs & QA
|
|
-20K
|
$15.97
|
-$319.40K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$16.69
|
-$83.45K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$17.24
|
-$34.48K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$17.09
|
-$34.18K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.67
|
-$88.35K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$17.84
|
-$35.68K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$17.70
|
-$35.40K
|
|
SEC
|
MAYNOR KATHLEEN A
|
VP of Regulary Affairs & QA
|
|
-20K
|
$17.49
|
-$349.80K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-5K
|
$17.80
|
-$89.00K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$17.63
|
-$88.15K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$17.95
|
-$35.90K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$13.80
|
-$27.60K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$13.99
|
-$69.95K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$14.02
|
-$28.04K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$13.62
|
-$27.24K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-5K
|
$14.00
|
-$70.00K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-24K
|
$14.00
|
-$329.00K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$13.73
|
-$68.65K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$13.05
|
-$26.10K
|
|
SEC
|
SANTILLI RONALD J
|
CFO & VP of Finance and Admin.
|
|
-1.5K
|
$14.00
|
-$21.00K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$12.27
|
-$24.54K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-2K
|
$12.22
|
-$24.44K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$12.46
|
-$62.30K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-20K
|
$12.57
|
-$251.40K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$12.48
|
-$24.96K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$12.94
|
-$64.70K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$12.65
|
-$25.30K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$12.39
|
-$61.95K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$12.10
|
-$24.20K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$12.18
|
-$60.90K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$12.15
|
-$24.30K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-5K
|
$12.60
|
-$63.00K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$12.65
|
-$25.30K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$12.82
|
-$38.46K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$12.18
|
-$24.36K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$11.50
|
-$34.50K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$11.80
|
-$23.60K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$12.15
|
-$36.45K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$11.36
|
-$22.72K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$11.39
|
-$34.17K
|
|
SEC
|
MAYNOR KATHLEEN A
|
VP of Regulary Affairs & QA
|
|
-10K
|
$11.25
|
-$112.50K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$11.41
|
-$22.82K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$11.11
|
-$33.33K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$10.10
|
-$20.20K
|
|
SEC
|
APFELBERG DAVID B
|
N/A
|
|
-5K
|
$11.10
|
-$55.50K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$10.60
|
-$31.80K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-7K
|
$10.84
|
-$75.88K
|
|
SEC
|
MAYNOR KATHLEEN A
|
VP of Regulary Affairs & QA
|
|
-5K
|
$10.95
|
-$54.75K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-13K
|
$10.88
|
-$141.44K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-16K
|
$11.01
|
-$172.86K
|
|
SEC
|
GOLLNICK DAVID A
|
VP of Research and Development
|
|
-14K
|
$11.26
|
-$161.02K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$10.50
|
-$21.00K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$10.70
|
-$32.10K
|
|
SEC
|
LEVERNIER MICHAEL J
|
VP of Clinical Development
|
|
-2K
|
$9.34
|
-$18.68K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$9.51
|
-$28.53K
|
|
SEC
|
CONNORS KEVIN P
|
President and CEO
|
|
-3K
|
$10.30
|
-$30.90K
|
|
SEC
|
CAMPBELL WHITE ANNETTE
|
N/A
|
|
+33K
|
$14.00
|
+$466.66K
|
|